Pharma Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Academy of General Dentistry
Treatment drug may cause jawbone to die
July 4th, 2006
Breast cancer patients, individuals at risk for osteoporosis, and individuals undergoing certain types of bone cancer therapies often take drugs that contain bisphosphonates. A newly published case report shows bisphosphonates may place patients at risk for developing osteonecrosis of the jaws (a rotting of the jaw bones). The report and literature review appeared in a recent issue of General Dentistry, the Academy of General Dentistry's (AGD) clinical, peer-reviewed journal. Bisphosphonates are a family of drugs used to prevent and treat osteoporosis, multiple myeloma, Paget's disease (bone cancers), and bone metastasis from other cancers....
Source: Pharma Law Weekly (2006-07-04)
|
